Biotage AB (publ)
BITGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,056,000 | $1,862,000 | $1,566,000 | $1,232,000 |
| % Growth | 10.4% | 18.9% | 27.1% | – |
| Cost of Goods Sold | $767,000 | $713,000 | $618,000 | $477,000 |
| Gross Profit | $1,289,000 | $1,149,000 | $948,000 | $755,000 |
| % Margin | 62.7% | 61.7% | 60.5% | 61.3% |
| R&D Expenses | $180,000 | $159,000 | $109,000 | $91,000 |
| G&A Expenses | $235,000 | $194,000 | $150,000 | $117,000 |
| SG&A Expenses | $704,000 | $597,000 | $529,000 | $404,000 |
| Sales & Mktg Exp. | $469,000 | $403,000 | $379,000 | $287,000 |
| Other Operating Expenses | $22,000 | $79,000 | -$17,000 | -$11,000 |
| Operating Expenses | $906,000 | $835,000 | $621,000 | $484,000 |
| Operating Income | $383,000 | $314,000 | $327,000 | $271,000 |
| % Margin | 18.6% | 16.9% | 20.9% | 22% |
| Other Income/Exp. Net | -$55,000 | -$11,000 | $21,000 | -$2,000 |
| Pre-Tax Income | $328,000 | $303,000 | $348,000 | $269,000 |
| Tax Expense | $44,000 | $57,000 | $80,000 | $64,000 |
| Net Income | $284,000 | $246,000 | $268,000 | $205,000 |
| % Margin | 13.8% | 13.2% | 17.1% | 16.6% |
| EPS | 3.55 | 0.33 | 0.39 | 0.35 |
| % Growth | 975.8% | -15.4% | 11.4% | – |
| EPS Diluted | 3.55 | 0.33 | 0.39 | 0.34 |
| Weighted Avg Shares Out | 80,029 | 73,853 | 65,984 | 65,355 |
| Weighted Avg Shares Out Dil | 80,100 | 73,994 | 66,184 | 65,465 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11,948 | $8,945 | $1,952 | $0 |
| Interest Expense | $42,812 | $40,749 | $4,881 | $2,985 |
| Depreciation & Amortization | $185,000 | $149,000 | $101,000 | $75,000 |
| EBITDA | $530,000 | $465,000 | $454,000 | $347,000 |
| % Margin | 25.8% | 25% | 29% | 28.2% |